CD4 and neoplasm: By contrast, the frequency of tumor-infiltrating CD4+Foxp3+Tregs with the same TCR specificities as Teffs dropped by over 50% upon the DTA-1 treatment, but the unexpected diversity of their TCRs increased at the levels of amino acid and nucleotide sequences.